drugset / Trial / NCT01520753

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

NCT01520753

Phase 3 Completed 16 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare two different active treatment regimens of biphasic insulin aspart in subjects with type 2 diabetes.

Timeline

Start
1999-03
Primary completion
1999-06
Completion
1999-06

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic Subcutaneous